Livrables
A final report on the Liaison activities with external stakeholders will be prepared.
1st scientific report on Structure Activity Relationship studies2nd report on reviews of QMS of EU-NCL
2nd scientific report on mode of action studies
Liaison activities with external stakeholders – 1st report
2nd Prioritized list of candidate technologies
3rd report on reviews of QMS of EU-NCL
1st completed survey with regulatory bodies
Activities to promote innovation through partnership with industry– 3rd report
2nd Completed survey with regulatory bodies
1st report on reviews of QMS of EU-NCL
CMS implemented
1st Data management plan
1st List of candidate technologies
2nd Data management plan
2nd report on the testing and optimization of novel technologies
1st report on modeling of analytical decision process
3rd Completed survey with regulatory bodies
3rd Data Management Plan
3rd Sample Management Report
1st report on the testing and optimization of novel technologiesActivities to promote innovation through partnership with industry – 2nd report
Activities to promote innovation through partnership with industry– 2nd report
Activities to promote innovation through partnership with industry– 1st report2nd List of candidate technologies
2nd scientific report on Structure Activity Relationship studies
1st Prioritized list of candidate technologies
1st scientific report on mode of action studies
2nd report on modeling of analytical decision process
EU-NCL annual workshop –year 3
Publication of 1st TNA open call
Publication of “State-of-the-art” manuscript – version 1
EU-NCL annual workshop –year 2
Publication of “State-of-the-art” manuscript – version 2
EU-NCL annual workshop – year 4
EU-NCL website
Publication of 3rd TNA open call
Publications
Auteurs:
Dora Mehn, Patrizia Iavicoli, Noelia Cabaleiro, Sven Even Borgos, Fanny Caputo, Otmar Geiss, Luigi Calzolai, François Rossi, Douglas Gilliland
Publié dans:
International Journal of Pharmaceutics, Numéro 523/1, 2017, Page(s) 320-326, ISSN 0378-5173
Éditeur:
Elsevier BV
DOI:
10.1016/j.ijpharm.2017.03.046
Auteurs:
Fanny Caputo, Amandine Arnould, Maria Bacia, Wai Li Ling, Emilie Rustique, Isabelle Texier, Adriele Prina Mello, Anne-Claude Couffin
Publié dans:
Molecular Pharmaceutics, Numéro 16/2, 2018, Page(s) 756-767, ISSN 1543-8384
Éditeur:
American Chemical Society
DOI:
10.1021/acs.molpharmaceut.8b01033
Auteurs:
Sabrina Gioria, Fanny Caputo, Patricia Urbán, Ciarán Manus Maguire, Susanne Bremer-Hoffmann, Adriele Prina-Mello, Luigi Calzolai, Dora Mehn
Publié dans:
Nanomedicine, Numéro 13/5, 2018, Page(s) 539-554, ISSN 1743-5889
Éditeur:
Future Medicine Ltd.
DOI:
10.2217/nnm-2017-0338
Auteurs:
D. Mehn, F. Caputo, M. Rösslein, L. Calzolai, F. Saint-Antonin, T. Courant, P. Wick, D. Gilliland
Publié dans:
RSC Advances, Numéro 7/44, 2017, Page(s) 27747-27754, ISSN 2046-2069
Éditeur:
Royal Society of Chemistry
DOI:
10.1039/c7ra02432k
Auteurs:
F. Caputo, J. Clogston, L. Calzolai, M. Rösslein, A. Prina-Mello
Publié dans:
Journal of Controlled Release, Numéro 299, 2019, Page(s) 31-43, ISSN 0168-3659
Éditeur:
Elsevier BV
DOI:
10.1016/j.jconrel.2019.02.030
Auteurs:
Matthias Rösslein, Neill J. Liptrott, Andrew Owen, Patrick Boisseau, Peter Wick, Inge K. Herrmann
Publié dans:
Nanotoxicology, Numéro 11/2, 2017, Page(s) 147-149, ISSN 1743-5390
Éditeur:
Informa Healthcare
DOI:
10.1080/17435390.2017.1279361
Auteurs:
Adriele Prina-Mello
Publié dans:
Handbook of Nanomaterials for Cancer Theranostics, 2018, Page(s) 517-535, ISBN 9780-128133392
Éditeur:
Elsevier
DOI:
10.1016/b978-0-12-813339-2.00017-7
Recherche de données OpenAIRE...
Une erreur s’est produite lors de la recherche de données OpenAIRE
Aucun résultat disponible